明基醫 4116 Cash Flow
41.25+0.45 (+1.10%)11/13 Close · Vol. 97 lots
—
Line items
Auto Read
Latest
Latest2026 Q3
明基醫(4116)'s 2026 Q3 financial highlights: Operating CF 157.4M · Free cash flow 1.25B · Investing CF 1.10B.
Operating CF
157.4M
Free cash flow
1.25B
Investing CF
1.10B
About This Metric
Definition
Quarterly figures from the income statement, balance sheet and cash flow statement.
How to Read
Operating cash flow often reveals earnings quality better than reported net income.
Source
MOPS
How much time do you spend wiring APIs, pulling data, and debugging — instead of thinking about strategy? Describe the signal, and Blave Agent researches and backtests it.
See what Blave Agent can do →